Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial.
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Netherlands
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Erasmus Medical Center Rotterdam
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2014-003834-21
- Official title
Show the full official title
Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial.
Recruitment & locations
Netherlands
Registry details
- Netherlands — Prematurely Ended
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Erasmus Medical Center Rotterdam, a hospital or academic medical center.
Is this study still recruiting?
The historical registry lists this study as terminated.
